Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815223) titled 'A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradi... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815847) titled 'Effects of Oral Fruit Concentrate Supplementation in Pre-Metabolic Syndrome' ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815977) titled 'Effect of Cover Screws and Healing Abutments on Marginal Bone Loss' on Sept. ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816029) titled 'Append Prague Study' on Sept. 7. Study Type: Interventional Study Design: ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816081) titled 'Cerebral Oximetry During Awake Carotid Endarterectomy' on Sept. 7. Study Typ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816133) titled 'Study on the Ultrasound and Biological Characteristics of Atypical Endometrio... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816185) titled 'A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)' on Sept. 7. St... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816289) titled 'Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-rel... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816341) titled 'Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia' ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816380) titled 'A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 Versus Crizo... Read More